The assessment of pathological response to neoadjuvant chemotherapy in muscle- invasive bladder cancer patients with DCE- MRI and DWI: a systematic review and meta-analysis

被引:1
|
作者
Zong, Ruilong [1 ]
Ma, Xijuan [1 ]
Shi, Yibing [1 ]
Geng, Li [2 ]
机构
[1] Xuzhou Cent Hosp, Dept Radiol, Xuzhou 221000, Peoples R China
[2] Xuzhou Med Univ, Affiliated Hosp, Dept Radiol, Xuzhou, Peoples R China
来源
BRITISH JOURNAL OF RADIOLOGY | 2023年 / 96卷 / 1150期
关键词
CONTRAST-ENHANCED MRI; URINARY-BLADDER; TUMOR HETEROGENEITY; CELL CARCINOMA; ANGIOGENESIS; DIFFUSIVITY; PREDICTION; CISPLATIN;
D O I
10.1259/bjr.20230239
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: The purpose of this meta-analysis was to determine the value of dynamic contrast-enhanced- MRI (DCE- MRI) and diffusion-weighted imaging (DWI) in evaluating the pathological response of muscle invasive bladder cancer (MIBC) to neoadjuvant chemotherapy (NAC), and further indirectly compare the diagnostic performance of DCE- MRI and DWI. Methods: Literatures associated to DCE- MRI and DWI in the evaluation of pathological response of MIBC to NAC were searched from PubMed, Cochrane Library, web of science, and EMBASE databases. The quality assessment of diagnostic accuracy studies 2 tool was used to assess the quality of studies. Pooled sensitivity (SE), specificity (SP), positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and the area under the receiver operating characteristic curves (AUC) with their 95% confidence intervals (CIs) were calculated to evaluate the diagnostic performance of DCE- MRI and DWI in predicting the pathological response to NAC in patients with MIBC. Results: There were 11 studies involved, 6 of which only underwent DCE-MRI examination, 4 of which only underwent DWI examination, and 1 of which underwent both DCE-MRI and DWI examination. The pooled SE, SP, PLR, NLR, DOR of DCE- MRI were 0.88 (95% CI: 0.78- 0.93), 0.88 (95% CI: 0.67-0.96), 7.4 (95% CI: 2.3-24.2), 0.14 (95% CI: 0.07-0.27), and 53 (95% CI: 10-288), respectively. The pooled SE, SP, PLR, NLR, DOR of DWI were 0.83 (95% CI: 0.75-0.88), 0.88 (95% CI: 0.81-0.93), 7.1 (95% CI: 4.3-11.7), 0.20 (95% CI: 0.14-0.28), and 36 (95% CI:18-73), respectively. The AUCs of SROC curve for DCE- MRI and DWI were 0.93 (95% CI: 0.91-0.95) and 0.92 (95% CI: 0.89-0.94), respectively. There were no significant differences between DWI and DCE- MRI for SE, SP, and AUC. Conclusion: This meta-analysis demonstrated high diagnostic performance of both DCE- MRI and DWI in predicting the pathological response to NAC in MIBC. DWI might be a potential substitute for DCE- MRI, with no significant difference in diagnostic performance between the two. However, caution should be taken when applying our results, as our results were based on indirect comparison. Advances in knowledge: No previous studies have comprehensively analysed the value of DCE- MRI and DWI in evaluating the pathological response to NAC in MIBC. According to the current study, both DCE- MRI and DWI yielded high diagnostic performance, with the AUCs of 0.93 and 0.92, respectively. Indirect comparison no significant difference in the diagnostic performan-ceof DCE- MRI and DWI.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Role of Neoadjuvant Chemotherapy in Breast Cancer Patients: Systematic Review and Meta-analysis
    Pathak, Mona
    Deo, S. V. S.
    Dwivedi, Sada Nand
    Sreenivas, Vishnubhatla
    Thakur, Bhaskar
    Julka, Pramod Kumar
    Rath, G. K.
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2019, 40 (01) : 48 - 62
  • [32] Systematic Review and Meta-Analysis on the Efficacy of Chemotherapy with Transurethral Resection of Bladder Tumors as Definitive Therapy for Muscle Invasive Bladder Cancer
    Moran, George W.
    Li, Gen
    Robins, Dennis J.
    Matulay, Justin T.
    McKiernan, James M.
    Anderson, Christopher B.
    BLADDER CANCER, 2017, 3 (04) : 245 - 258
  • [33] Re: A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer
    Sagalowsky, Arthur I.
    EUROPEAN UROLOGY, 2013, 63 (03) : 579 - 580
  • [34] The accuracy of breast MRI radiomic methodologies in predicting pathological complete response to neoadjuvant chemotherapy: A systematic review and network meta-analysis
    O'Donnell, J. P. M.
    Gasior, S. A.
    Davey, M. G.
    O'Malley, E.
    Lowery, A. J.
    McGarry, J.
    O'Connell, A. M.
    Kerin, M. J.
    McCarthy, P.
    EUROPEAN JOURNAL OF RADIOLOGY, 2022, 157
  • [35] A systematic review and meta-analysis of neoadjuvant chemotherapy for bladder cancer between ddMVAC and GC regimen
    Liu, Tieshi
    Jiang, Guiya
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (05) : 195.e19 - 195.e25
  • [36] A Systematic Review and Meta-analysis of Chemoablation for Non-muscle-invasive Bladder Cancer
    Yanagisawa, Takafumi
    Quhal, Fahad
    Kawada, Tatsushi
    Mostafaei, Hadi
    Motlagh, Reza Sari
    Laukhtina, Ekaterina
    Rajwa, Pawel
    von Deimling, Markus
    Bianchi, Alberto
    Pallauf, Maximilian
    Majdoub, Muhammad
    Pradere, Benjamin
    Moschini, Marco
    Karakiewicz, Pierre I.
    Teoh, Jeremy Yuen-Chun
    Miki, Jun
    Kimura, Takahiro
    Shariat, Shahrokh F.
    EUROPEAN UROLOGY FOCUS, 2023, 9 (03): : 463 - 479
  • [37] The Role of 18F-FDG PET/CT and MRI in Assessing Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis
    Liu, Qiufang
    Wang, Chen
    Li, Panli
    Liu, Jianjun
    Huang, Gang
    Song, Shaoli
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [38] A Review of Molecular Predictors of Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer
    Degener, Stephan
    Mata, Douglas A.
    Youssef, Ramy
    Goedde, Daniel
    Tandogdu, Zafer
    Roth, Stephan
    von Rundstedt, Friedrich-Carl
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2018, 18 (13) : 1133 - 1142
  • [39] Quantifying the absolute benefit of neoadjuvant chemotherapy followed by definitive therapy in patients with muscle-invasive bladder cancer: A systematic review and meta-analysis.
    Ikram, Waleed
    Naqvi, Syed Arsalan Ahmed
    Raina, Ammad
    Fatima, Ezza
    Siddiqi, Rabbia
    Islam, Mahnoor
    Asghar, Noureen
    Khakwani, Kaneez Zahra Rubab
    Khan, Ahsan Masood
    Hussain, Syed A.
    Bryce, Alan Haruo
    Bin Riaz, Irbaz
    Singh, Parminder
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [40] Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: A systematic review and meta-analysis
    Winquist, E
    Kirchner, TS
    Segal, R
    Chin, J
    Lukka, H
    JOURNAL OF UROLOGY, 2004, 171 (02): : 561 - 569